Phronesis Artificial Intelligence
Phronesis Artificial Intelligence, Inc. develops advanced pharmaceutical software for fully autonomous de novo drug design and screening. Their user-friendly platform, LIME, leverages state-of-the-art deep learning and extensive small molecular data to drastically reduce timelines, costs, and failure rates in early-stage drug development. The company aims to transform drug discovery by expanding beyond traditional hit compound design to comprehensive molecular optimization and predictive modeling, supported by AI research, computational resources, and laboratory data validation. This approach positions Phronesis AI as a cutting-edge solution provider in the pharmaceutical AI market, targeting small and medium-sized pharma companies to enhance their drug discovery capabilities and competitiveness.
Phronesis Artificial Intelligence
Phronesis Artificial Intelligence, Inc. develops advanced pharmaceutical software for fully autonomous de novo drug design and screening. Their user-friendly platform, LIME, leverages state-of-the-art deep learning and extensive small molecular data to drastically reduce timelines, costs, and failure rates in early-stage drug development. The company aims to transform drug discovery by expanding beyond traditional hit compound design to comprehensive molecular optimization and predictive modeling, supported by AI research, computational resources, and laboratory data validation. This approach positions Phronesis AI as a cutting-edge solution provider in the pharmaceutical AI market, targeting small and medium-sized pharma companies to enhance their drug discovery capabilities and competitiveness.